QUICKLINKS AND VIEW OPITONS
2.1% to 2.6% of patients given Qnexa (phentermine + Topamax) dropped out due to cognitive effects
Thursday, October 29, 2009 1:42 pm Email this article
Among patients given a full dose of Qnexa (15 mg Phentermine plus 92 mg Topamax), 2.1% and 2.6% dropped out of two study due to cognitive side effects such as "disturbance in attention" or "forgetfulness" compared to 0.3% and 0.8% of those given the placebo reports TheStreet.com.
This had not been previously disclosed by Vivus, the company developing this drug.
Other articles about Qnexa are posted here.
Articles on the same subject can be found here:
Please feel free to share your comments about this article.
© Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.